Bronchitis
📧 Sign up to get email alerts when something new happens for Bronchitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care. [NA]
The document describes a clinical trial evaluating whether osteopathic manipulative treatment (OMT) improves outcomes for newly diagnosed re…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Clinical Evaluation of the RheOx Bronchial Rheoplasty System [NA]
This document provides an update on a clinical study evaluating the RheOx bronchial rheoplasty system for chronic bronchitis and chronic obs…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients [Phase 4]
A Phase 4 clinical trial update indicates that Elixirium Thymi Compositum is enrolling (by invitation) to evaluate its efficacy in pediatric…
-
FDA approval · 2025-04-15FDA Approved: RUGBY MUCUS RELIEF ER — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Mucus Relief ER (guaifenesin) from Rugby Laboratories, allowing the generic product to be …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Development of the Drug and Alcohol Respiratory Health Test
A clinical trial update from King's College London on developing a respiratory health test related to drug and alcohol use; the study is not…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study
This is a status update for the BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction study, a Swedish trial investigatin…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease
This entry notes an ongoing Karolinska Institutet clinical study investigating smoking-related chronic obstructive pulmonary disease (includ…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
A recruiting clinical trial aims to identify multiple pulmonary diseases by using volatile organic compound biomarkers in exhaled breath.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Pulmonary Deposition of Ultrasound Rock Salt Aerosol Inhalation Therapy [NA]
A clinical trial evaluating pulmonary deposition of ultrasound-assisted rock salt aerosol inhalation therapy. The study is not yet recruitin…
-
FDA approval · 2025-03-14FDA Approved: ACETYLCYSTEINE — Original Application (Cameron Pharmaceuticals)
FDA approves Cameron Pharmaceuticals' Acetylcysteine original application (ANDA 214177). Acetylcysteine is used as a mucolytic and as an ant…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis [Phase 2]
Phase II randomized, double-blind, placebo-controlled trial evaluating MEDI3506 in chronic obstructive pulmonary disease with chronic bronch…
-
FDA approval · 2025-02-21FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for sulfamethoxazole and trimethoprim, granting approval of a generic p…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Evaluation of Immunological, Microbiological and Metabolomic Profiles in COPD
A completed clinical trial from Medical University of Warsaw studied immunological, microbiological, and metabolomic profiles in chronic obs…
-
FDA approval · 2025-02-12FDA Approved: ACETYLCYSTEINE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for acetylcysteine from Somerset Therapeutics, LLC, granting approval for a generic acetylcysteine pro…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Evaluating the Potential of Large Language Models for Respiratory Disease Consultations [NA]
This completed clinical trial evaluated the potential of large language models to assist respiratory disease consultations. It covered multi…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup [Phase 1]
Phase 1 crossover bioequivalence study comparing SCMC-Lys Salt powder to SCMC-Lys Salt syrup in bronchitis; results have been posted after c…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting [NA]
A completed clinical trial by Neopharm Bulgaria Ltd. investigating treatment of adults with acute bronchitis in primary healthcare settings.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms. [NA]
A terminated clinical trial assessed the effect of switching COPD patients with chronic bronchitis symptoms from cigarette smoking to the To…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: HHHFA in COPD Patients, With Chronic Bronchitis [NA]
Completed clinical trial evaluating HHHFA in patients with chronic obstructive pulmonary disease and chronic bronchitis. Results have been p…
-
FDA approval · 2024-09-05FDA Approved: THEOPHYLLINE — Original Application (Strides Pharma Science Limited)
FDA approves a generic Theophylline from Strides Pharma Science Limited via an Original Application (ANDA).
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD [Phase 2]
This Phase 2 trial in COPD patients investigates blocking thymic stromal lymphopoietin (TSLP) to reduce airway inflammation and modify epith…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease [NA]
A clinical trial evaluating telehealth and onsite maintenance exercise for people with chronic lung diseases, currently recruiting.
-
FDA approval · 2024-07-11FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Micro Labs Limited under ANDA217805.
-
FDA approval · 2024-06-24FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for sulfamethoxazole and trimethoprim by Prasco Laboratories. This action confirms the approval of t…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: RejuvenAir® System Trial for COPD With Chronic Bronchitis [NA]
The RejuvenAir System trial for COPD with chronic bronchitis is currently active but not recruiting.